BioCentury
ARTICLE | Clinical News

Synta preclinical data

December 21, 2009 8:00 AM UTC

In AML cell lines in vitro, elesclomol displayed potent anti-leukemic effects at concentrations as low as 10 nM. Data were presented at the American Society of Hematology meeting in New Orleans. In Ma...